CRISIL Affirms "A1+" Rating on Godrej Agrovet's Rs. 1,500 Crore Commercial Paper Programme
Godrej Agrovet Limited has received a rating affirmation from CRISIL regarding its commercial paper programme. The rating was issued based on the company’s financial strength and is described as indicating very strong safety concerning timely payment of financial obligations.CRISIL confirmed the "A1+" rating for Godrej Agrovet's Commercial Paper program, which is valued at Rs. 1,500 Crore. This designation signifies that securities carrying this rating are considered to possess a low credit risk and offer a very strong degree of safety regarding the timely fulfillment of financial obligations.
The key details of the rating are as follows:
| Detail | Specification |
|---|---|
| Rating Agency | CRISIL |
| Date of Rating | July 6, 2026 |
| Rated Instrument | Commercial Paper Programme |
| Program Value | Rs. 1,500 Crore |
| Rating Granted | CRISIL A1+ |
The affirmation emphasizes the stability of Godrej Agrovet's financial standing relative to its commercial paper instruments, indicating that such securities carry the lowest credit risk within their class.
GODREJAGRO Stock Price Movement
As of 11:13 AM, shares of Godrej Agrovet Limited are slipping by 0.85% in live trading, currently trading at ₹563.25 after shedding ₹4.85 per share. The stock has seen a traded volume of 24,554 shares during the current market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.